HR Execs on the Move

Dynatronics

www.dynatronics.com

 
Dynatronics is a medical device company committed to providing high-quality restorative products designed to accelerate one to their optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company is headquartered in greater Salt Lake City, Utah, and its products are marketed under a portfolio of brands including Bird & Cronin®, Dynatron Solaris®, Hausmann, Physician`s Choice®, and PROTEAM™.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details
John Krier
Chief Financial Officer and Chief Executive Officer Profile
Justin Nuahn
Human Resources Director Profile
Norm Roegner
Chief Financial Officer Profile
Norm Roegner
Chief Financial Officer Profile

Similar Companies

Futuremed America Inc

Futuremed America Inc is a Granada Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Achoo Allergy and Air Products

Achoo Allergy & Air Products is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

north mountain medical and rehab

north mountain medical and rehab is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.

Chain Drug Consortium

Chain Drug Consortium is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.